DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    Clinical Investigator: Module 2 - Conducting the Study Feb 01, 2015 ACPE, CME Online Instruction North America Online
    Clinical Investigator: Module 1 - Study Preparation and Initiation Feb 01, 2015 ACPE, CME Online Instruction North America Online
    Informed Consent Feb 01, 2015 ACPE Online Instruction North America Online
    Crisis Management Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Database Management Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Literature Evaluation Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Literature Searching Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Medical Inquiries Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Medical Writing Feb 01, 2015 IACET Online Instruction North America Online
    Product Labeling Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Regulatory Issues Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Statistics for Medical Communications Professionals Feb 01, 2015 ACPE, IACET Online Instruction North America Online
    Generic Drug Labeling Proposed Rule and Safety Updates Feb 01, 2015 Online Instruction Global Online
    Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Feb 01, 2015 Online Instruction Global Online
    Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Feb 01, 2015 Online Instruction Global Online
    The Role of the Clinical Data Manager Feb 01, 2015 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions Feb 01, 2015 Online Instruction Global Online
    Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Feb 01, 2015 Online Instruction Global Online
    Variations in the European Union: CMC/Quality Changes Feb 01, 2015 Online Instruction Global Online
    Proarrhythmia Feb 01, 2015 Online Instruction Global Online
    Facets of Drug-Induced Kidney Injury and Regulatory Perspective Feb 01, 2015 Online Instruction Global Online
    Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Feb 01, 2015 Online Instruction Global Online
    Pharmacovigilance and Risk Management: Patient Perspective Feb 01, 2015 Online Instruction Global Online
    Drug Safety Regulatory Requirements Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    Premarketing Clinical Trial Safety Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    Postmarketing Safety Management Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    Basics of Signal Detection and Pharmacoepidemiology Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    Safety Audits and Inspections Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Feb 01, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Feb 01, 2015 Online Instruction Global Online
    Pharmacovigilance and Global Harmonization Updates Feb 01, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Feb 01, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Feb 01, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Feb 01, 2015 Online Instruction Global Online
    Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Feb 01, 2015 Online Instruction Global Online
    Negotiation and Influence Feb 01, 2015 Online Instruction Global Online
    Introduction to Drug Safety Feb 01, 2015 ACPE, IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection Feb 01, 2015 Online Instruction Global Online
    Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Feb 01, 2015 Online Instruction Global Online
    Clinical Statistics for Nonstatisticians Feb 01, 2015 Online Instruction Global Online
    Advanced Clinical Statistics for Nonstatisticians Feb 01, 2015 Online Instruction Global Online
    Development of a Clinical Study Report Feb 01, 2015 Online Instruction Global Online
    Art of Writing a Clinical Overview Feb 01, 2015 Online Instruction Global Online
    Introductory Principles and Application of Risk Management within Clinical Operations Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Feb 01, 2015 Online Instruction Global Online
    Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Feb 01, 2015 Online Instruction Global Online
    Disruptive Innovation in Medical Information Feb 01, 2015 Online Instruction Global Online
    A Tour of FDA Feb 01, 2015 Online Instruction Global Online
    A Tour of Health Canada Feb 01, 2015 Online Instruction Global Online
    A Tour of Health Europe Feb 01, 2015 Online Instruction Global Online
    Aspects of Regulatory History Feb 01, 2015 Online Instruction Global Online
    Bioresearch Monitoring Program (BIMO): Introduction Feb 01, 2015 Online Instruction Global Online
    The Clinical Development Process: Investigational Product, Plan, and Data Management Feb 01, 2015 Online Instruction Global Online
    Ethical Review Boards Feb 01, 2015 Online Instruction Global Online
    Ethics as the Foundation to Clinical Research Feb 01, 2015 Online Instruction Global Online
    Awareness of FDA Inspections for Pharmaceutical Manufacturers Feb 01, 2015 Online Instruction Global Online
    Biotechnology: An Overview of Compliance Considerations Feb 01, 2015 Online Instruction Global Online
    Change Control Feb 01, 2015 Online Instruction Global Online
    Clinical Trial Audits and Consequences of Non-Compliance Feb 01, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Medical Device Industry Feb 01, 2015 Online Instruction Global Online
    European Union Clinical Trials Directive Feb 01, 2015 Online Instruction Global Online
    GMP Principals of SOPs Feb 01, 2015 Online Instruction Global Online
    GMP Updates - Enforcement Changes at the New FDA Feb 01, 2015 Online Instruction Global Online
    GMPs for API Bulk Manufacturers Feb 01, 2015 Online Instruction Global Online
    Good Clinical Practices (GCPs) for New Product Investigations Feb 01, 2015 Online Instruction Global Online
    Good Laboratory Practices (GLPs) Feb 01, 2015 Online Instruction Global Online
    GxPs Feb 01, 2015 Online Instruction Global Online
    HIPAA - The Impact on Clinical Research Feb 01, 2015 Online Instruction Global Online
    Introduction to GMPs Feb 01, 2015 Online Instruction Global Online
    Investigational Product Development Feb 01, 2015 Online Instruction Global Online
    ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Feb 01, 2015 Online Instruction Global Online
    Key Concepts of Process Validation Feb 01, 2015 Online Instruction Global Online
    Laboratory Specimens for Clinical Research Feb 01, 2015 Online Instruction Global Online
    Medical Device Safety Reporting Feb 01, 2015 Online Instruction Global Online
    Orientation to GMP Compliance Feb 01, 2015 Online Instruction Global Online
    Overview of the Clinical Research Process Feb 01, 2015 Online Instruction Global Online
    Part 11: Electronic Records and Signatures - Application Feb 01, 2015 Online Instruction Global Online
    Part 11: Electronic Records; Electronic Signatures Feb 01, 2015 Online Instruction Global Online
    Principles of Good Documentation Feb 01, 2015 Online Instruction Global Online
    Protection of Human Subjects in Clinical Trials Feb 01, 2015 Online Instruction Global Online
    Selecting and Managing Clinical Contract Research Organizations (CROs) Feb 01, 2015 Online Instruction Global Online
    Understanding Post-Approval Changes Feb 01, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Pharmaceutical Industry Feb 01, 2015 Online Instruction Global Online
    Basics of the PhRMA Code Feb 01, 2015 Online Instruction Global Online
    Basics of AdvaMed Code Feb 01, 2015 Online Instruction Global Online
    Eucomed Guidelines on Interactions with Healthcare Professionals Feb 01, 2015 Online Instruction Global Online
    Introduction to Medical Device Health Care Compliance Feb 01, 2015 Online Instruction Global Online
    Foreign Corrupt Practices Act Feb 01, 2015 Online Instruction Global Online
    Global Anti-bribery Feb 01, 2015 Online Instruction Global Online
    Variations to Marketing Authorisation in Europe Feb 01, 2015 Online Instruction Global Online
    Registration of Monoclonal Antibodies Feb 01, 2015 Online Instruction Global Online
    How to Gain Approval to Market a Generic Medicinal Product in the USA Feb 01, 2015 Online Instruction Global Online
    Pharmacokinetics and Pharmacodynamics in Drug Registration Feb 01, 2015 Online Instruction Global Online
    Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Feb 01, 2015 Online Instruction Global Online
    Implementing Risk-Based Monitoring: Practical Approaches Feb 01, 2015 Online Instruction Global Online
    Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Feb 01, 2015 Online Instruction Global Online
    Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Feb 01, 2015 Online Instruction Global Online
    Fundamentals of Project Management for Nonproject Managers Feb 01, 2015 Online Instruction Global Online
    Planning and Managing Your Projects Feb 01, 2015 Online Instruction Global Online
    Preparing a Clinical Trial Budget Feb 01, 2015 Online Instruction Global Online
    Team Building and Development Feb 01, 2015 Online Instruction Global Online
    Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Feb 01, 2015 Online Instruction Global Online
    Introduction to the European Union Institutions and Regulatory Authority Feb 01, 2015 Online Instruction Global Online
    Introduction to US Institutions and Regulatory Authority (FDA) Feb 01, 2015 Online Instruction Global Online
    Introduction to Japanese Institutions and Regulatory Authorities Feb 01, 2015 Online Instruction Global Online
    Overview of the CTD and eCTD Feb 01, 2015 Online Instruction Global Online
    Introduction to the International Conference on Harmonisation (ICH) Feb 01, 2015 Online Instruction Global Online
    The Regulatory Development of a Drug Feb 01, 2015 Online Instruction Global Online
    Basics of Clinical Trials Feb 01, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Centralized Procedure Feb 01, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Mutual Recognition Procedure Feb 01, 2015 Online Instruction Global Online
    How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Feb 01, 2015 Online Instruction Global Online
    How to Register a New Drug in the USA Feb 01, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Decentralized Procedure Feb 01, 2015 Online Instruction Global Online
    Access to Unapproved Drugs through Compassionate Use Feb 01, 2015 Online Instruction Global Online
    Regulatory Requirements for the Conduct of Clinical Trials in Europe Feb 01, 2015 Online Instruction Global Online
    Orphan Drugs in the USA, European Union, and Japan Feb 01, 2015 Online Instruction Global Online
    Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Feb 01, 2015 Online Instruction Global Online
    Meeting Opportunities with Regulatory Agencies Feb 01, 2015 Online Instruction Global Online
    How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Feb 01, 2015 Online Instruction Global Online
    Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Feb 01, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Feb 01, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Feb 01, 2015 Online Instruction Global Online
    Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Feb 01, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Postmarketing Feb 01, 2015 Online Instruction Global Online
    Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Feb 01, 2015 Online Instruction Global Online
    The Future of Personalized Medicine and Companion Diagnostics Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Feb 01, 2015 Online Instruction Global Online
    Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Feb 01, 2015 Online Instruction Global Online
    Basics of the IND Feb 01, 2015 Online Instruction Global Online
    Basics of the NDA Feb 01, 2015 Online Instruction Global Online
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Feb 01, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Feb 01, 2015 Online Instruction Global Online
    Supplements and Other Changes to an Approved Application Feb 01, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Feb 01, 2015 Online Instruction Global Online
    5th DIA Labeling Workshop in Japan Feb 03, 2015 Meetings Japan Tokyo, Japan
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Feb 05, 2015 IACET Online Instruction Global Online
    Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing Feb 09, 2015 In-Person Instruction Europe London, United Kingdom
    1st Maghreb Regulatory Conference Feb 10, 2015 Meetings Europe Algiers, Algeria
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Feb 10, 2015 IACET Online Instruction Global Online
    Bayesian Methods for Drug Safety Evaluation and Signal Detection Feb 10, 2015 IACET In-Person Instruction North America Arlington, VA, United States
    Use of Historical Data in Clinical Trials Feb 10, 2015 IACET In-Person Instruction North America Arlington, VA, United States
    Joint Adaptive Design and Bayesian Statistics Conference: Drivers of Efficiency in Modern Medical Product Development Feb 11, 2015 IACET Meetings North America Arlington, VA, United States
    ICH endorsed PhV training course Feb 12, 2015 In-Person Instruction Europe Algiers, Algeria
    EudraVigilance - electronic reporting of ICSRs in the EEA Feb 16, 2015 In-Person Instruction Europe London, United Kingdom
    OPDP/APLB and Compliance 101: A Primer Feb 17, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment Feb 18, 2015 ACPE, IACET Meetings North America Washington, DC, United States
    eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Feb 19, 2015 In-Person Instruction Europe London, United Kingdom
    Art of Writing a Clinical Overview Feb 24, 2015 IACET Online Instruction Global Online
    Introduction to Signal Detection and Data Mining Mar 02, 2015 IACET In-Person Instruction North America Washington, DC, United States
    eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Mar 02, 2015 In-Person Instruction Europe Madrid, Spain
    Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Mar 03, 2015 Online Instruction Global Online
    EudraVigilance - electronic reporting of ICSRs in the EEA Mar 04, 2015 In-Person Instruction Europe Madrid, Spain
    Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Mar 05, 2015 IACET Online Instruction Global Online
    Benefit/Risk Management Mar 10, 2015 In-Person Instruction Europe Hamburg, Germany
    Essentials of European Regulatory Affairs Mar 10, 2015 In-Person Instruction Europe Hamburg, Germany
    Introduction to Pharmacovigilance and Rules for Expedited Reporting of Individual Case Safety Reports (ICSRs) in Europe Mar 10, 2015 In-Person Instruction Europe London, United Kingdom
    Preparing a Clinical Trial Budget Mar 10, 2015 IACET, PMI Online Instruction Global Online
    EudraVigilance - electronic reporting of ICSRs in the EEA Mar 11, 2015 In-Person Instruction Europe London, United Kingdom
    3rd DIA Clinical Operation & Monitoring Workshop in Japan Mar 12, 2015 Meetings Japan Tokyo, Japan
    Regulatory Affairs: The IND, NDA, and Postmarketing Mar 15, 2015 IACET In-Person Instruction North America Irvine, CA, United States
    Core Curriculum Mar 15, 2015 In-Person Instruction North America Glendale, AZ, United States
    Medical Communications: Compliance in 2015 Mar 16, 2015 In-Person Instruction North America
    EudraVigilance - electronic reporting of ICSRs in the EEA Mar 16, 2015 In-Person Instruction Europe Vienna, Austria
    Medical & Scientific Communications 2015 Annual Forum Mar 16, 2015 Meetings North America Glendale, AZ, United States
    eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Mar 19, 2015 In-Person Instruction Europe Vienna, Austria
    2nd DIA Risk Management Workshop in Japan Mar 19, 2015 Meetings Japan Tokyo, Japan
    Premarketing Clinical Safety and Pharmacovigilance Mar 23, 2015 IACET In-Person Instruction North America Washington, DC, United States
    Clinical Data Validation Workshop Mar 25, 2015 Meetings China
    EudraVigilance - Electronic Reporting of ICSRs in the EEA Mar 25, 2015 In-Person Instruction Europe Bucharest, Romania
    Preparing for a FDA Advisory Committee Meeting Mar 30, 2015 IACET In-Person Instruction North America Washington, DC, United States
    CMC Workshop 2015 Apr 13, 2015 Meetings North America Bethesda, MD, United States
    Information Day on ICH Apr 13, 2015 Meetings Europe Paris, France
    8th Annual Clinical Forum Apr 13, 2015 Meetings Europe Paris, France
    27th Annual EuroMeeting Apr 13, 2015 Meetings Europe Paris, France
    EM01: HOT TOPICS IN PHARMACOVIGILANCE AND ADVERSE REACTION REPORTING Apr 13, 2015 In-Person Instruction Europe Paris, France
    EM02: INTERACTIONS BETWEEN REGULATORY AND LEGAL IN INTELLECTUAL PROPERTY, PRODUCT LIABILITY AND COMPETITION Apr 13, 2015 In-Person Instruction Europe Paris, France
    EM03: ANALYSIS OF SAFETY DATA FROM CLINICAL TRIALS Apr 13, 2015 In-Person Instruction Europe Paris, France
    EM04: PRIVACY AND PERSONAL DATA PROTECTION IN DRUG DEVELOPMENT Apr 13, 2015 In-Person Instruction Europe Paris, France
    EM05: MOVING FROM RISK MANAGEMENT TO BENEFIT/RISK MANAGEMENT EMBEDDING PHARMACOVIGILANCE PRINCIPLES INTO THE PRODUCT LIFE CYCLE Apr 13, 2015 In-Person Instruction Europe Paris, France
    EM06: MODELLING AND SIMULATION Apr 13, 2015 In-Person Instruction Europe Paris, France
    CF01: A LEGAL UPDATE: RECENT AND CURRENT DEVELOPMENTS IN EUROPEAN PHARMACEUTICAL LAW Apr 13, 2015 In-Person Instruction Europe Paris, France
    CF02: ENSURING DATA QUALITY AND DETECTING POTENTIAL FRAUD/GCP MISCONDUCT Apr 13, 2015 In-Person Instruction Europe Paris, France
    Regulatory Affairs for Biologics Apr 14, 2015 IACET In-Person Instruction North America Bethesda, MD, United States
    EudraVigilance - electronic reporting of ICSRs in the EEA Apr 15, 2015 In-Person Instruction Europe Paris, France
    Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation Apr 20, 2015 In-Person Instruction North America Washington, DC, United States
    DIA/FDA Statistics 2015 Forum Apr 20, 2015 Meetings North America North Bethesda, MD, United States
    EudraVigilance - electronic reporting of ICSRs in the EEA Apr 20, 2015 In-Person Instruction Europe London, United Kingdom
    9th DIA Annual Conference in Japan for Asian New Drug Development Apr 20, 2015 Meetings Japan Tokyo, Japan
    eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Apr 23, 2015 In-Person Instruction Europe London, United Kingdom
    ICH endorsed PhV training course Apr 26, 2015 In-Person Instruction Europe Dakar, Senegal
    4th African Regulatory Conference Apr 27, 2015 Meetings Europe Dakar, Senegal
    Key Considerations for the Development and Marketing of Biosimilar Products Apr 27, 2015 In-Person Instruction North America Washington, DC, United States
    Key Considerations for Biosimilar R&D Workshop Apr 27, 2015 Meetings China
    Signal Management in Pharmacovigilance Apr 27, 2015 In-Person Instruction Europe Basel, Switzerland
    How to prepare for Pharmacovigilance Audits and Inspections Apr 28, 2015 In-Person Instruction Europe Basel, Switzerland
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Apr 29, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    EudraVigilance - electronic reporting of ICSRs in the EEA May 04, 2015 In-Person Instruction Europe San Marino, San Marino
    Basics of the IND Phase May 04, 2015 IACET Online Instruction Global Online
    Oversight of Clinical Monitoring: Trends and Strategies May 05, 2015 IACET Online Instruction Global Online
    Introduction to Health Technology Assessment (HTA) May 06, 2015 In-Person Instruction Europe Amsterdam, Netherlands
    eRegulatory and Intelligence Annual Conference May 11, 2015 Meetings North America Philadelphia, PA, United States
    Electronic Submissions: The Next Era of Electronic Submissions May 14, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Essentials of Clinical Study Management May 18, 2015 In-Person Instruction Europe London, United Kingdom
    Pre-Marketing Clinical Safety May 18, 2015 In-Person Instruction Europe London, United Kingdom
    Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
    Introduction to Pharmacovigilance and Rules for Expedited Reporting of Individual Case Safety Reports (ICSRs) in Europe May 19, 2015 In-Person Instruction Europe London, United Kingdom
    EudraVigilance - electronic reporting of ICSRs in the EEA May 20, 2015 In-Person Instruction Europe London, United Kingdom
    The 7th DIA China Annual Meeting May 24, 2015 Meetings China Shanghai, China
    How to Prepare for a Safety Inspection Jun 01, 2015 IACET Online Instruction Global Online
    EudraVigilance - electronic reporting of ICSRs in the EEA Jun 03, 2015 In-Person Instruction Europe Berlin, Germany
    EudraVigilance - electronic reporting of ICSRs in the EEA Jun 08, 2015 In-Person Instruction Europe London, United Kingdom
    Medical Approach in Diagnosis and Management of ADRs Jun 10, 2015 In-Person Instruction Europe Montrouge, France
    eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Jun 11, 2015 In-Person Instruction Europe London, United Kingdom
    Diagnosis and Management of Drug-Induced Liver Injury (DILI) Jun 11, 2015 In-Person Instruction Europe Montrouge, France
    #20: The Sunshine Act: Understanding the Essentials of Compliance Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #21: Leadership: How to Organize and Lead People in a Work Group Jun 14, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    #22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #23: How to Prepare for an FDA Inspection Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #24: Pharmacogenomics and Companion Diagnostics: The Future of Clinical Trials, New Product Development and the Practice of Medicine Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    DIA 2015 51st Annual Meeting: Develop. Innovate. Advance. Jun 14, 2015 Meetings North America Washington, DC, United States
    #40: Analysis of Safety Data from Clinical Trials Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #41: Quality Oversight of CROs-Clinical Vendors Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #42: Fundamentals of ANDA Submissions and FDA Expectations Under GDUFA Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #43: Clinical Statistics for Nonstatisticians Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #44: Risk Management and Safety Communication Strategies Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #45: The Good Pharmacovigiliance Practices in the EU: Global Applications Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #30: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #31: Preparing for a US FDA Advisory Committee Meeting Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #32: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #33: Large-Scale Regulatory Functional Outsourcing: Emerging Trends, Challenges, and Decision Criteria Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #35: Ethical Issues in Clinical Trials Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 Online Instruction Global Online
    Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 10, 2015 ACPE, IACET In-Person Instruction North America Boston, MA, United States
    Development of a Clinical Study Report Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Clinical Project Management Aug 24, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    New Drug Product Development and Life Cycle Management Aug 26, 2015 In-Person Instruction North America Washington, DC, United States
    Overview of Drug Development in Japan Sep 02, 2015 Online Instruction Global Online
    DIA/FDA Oligonucleotide-based Therapeutic Conference 2015 Sep 09, 2015 Meetings North America Washington, DC, United States
    Adaptive Design in Clinical Trials: When and How to Apply Sep 14, 2015 In-Person Instruction North America Washington, DC, United States
    Clinical Project Management Part I Sep 16, 2015 In-Person Instruction Europe London, United Kingdom
    Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products Sep 17, 2015 Meetings North America North Bethesda, MD, United States
    Paediatric Investigation Plans (PIP) Sep 17, 2015 In-Person Instruction Europe London, United Kingdom
    Post-Authorisation Safety Studies (PASS) Sep 21, 2015 In-Person Instruction Europe Berlin, Germany
    Medical Devices: Regulation and lifecycle management Sep 21, 2015 In-Person Instruction Europe Vienna, Austria
    Quality by Design - New Concepts for Chemical and Biotech Product Development and Optimisation Sep 21, 2015 In-Person Instruction Europe Vienna, Austria
    Clinical Statistics for Nonstatisticians Sep 28, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Introduction to Signal Detection and Data Mining Oct 05, 2015 IACET Online Instruction Global Online
    Introduction to the role of QPPVs Oct 12, 2015 In-Person Instruction Europe
    9th European Forum for Qualified Person for Pharmacovigilance (QPPV) and Pre-Conference Workshop Oct 13, 2015 Meetings Europe London, United Kingdom
    Practical GCP Compliance Auditing of Trials and Systems Oct 14, 2015 In-Person Instruction Europe London, United Kingdom
    How to Prepare for Your Meeting with Health Authorities and Present Your Product Oct 14, 2015 In-Person Instruction Europe London, United Kingdom
    Clinical Statistics for Non-Statisticians Oct 15, 2015 In-Person Instruction Europe London, United Kingdom
    Risk Management and Safety Communication Oct 26, 2015 In-Person Instruction North America Washington, DC, United States
    Benefit/Risk Management Nov 03, 2015 In-Person Instruction Europe Montrouge, France
    Essentials of European Regulatory Affairs Nov 05, 2015 In-Person Instruction Europe Montrouge, France
    Signal Management in Pharmacovigilance Nov 05, 2015 In-Person Instruction Europe Montrouge, France
    Postmarketing Drug Safety & Pharmacovigilance Nov 09, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Nov 09, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Navigating Chemistry, Manufacturing and Controls Through the Drug Development Process Nov 09, 2015 In-Person Instruction North America Philadelphia, PA, United States
    Advanced Clinical Statistics for NonStatisticians Nov 11, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
    US Regulatory Affairs: A Comprehensive Review of Regulatory Procedures for INDs and NDAs in the US Nov 16, 2015 In-Person Instruction Europe London, United Kingdom
    Clinical Project Management Part II Nov 16, 2015 In-Person Instruction Europe London, United Kingdom
    Biopharmaceuticals, Biosimilars and Advanced Therapies - Development and Regulatory Framework in Europe Nov 25, 2015 In-Person Instruction Europe Vienna, Austria